Indian Cephalexin Exporters: Complete Supplier Ranking with Market Share — 516 Manufacturers (2026) — TransData Nexus

Q: Who is the largest cephalexin buyer importing from India?

ASCEND LABORATORIES, LLC C/O UPS (UNITED STATES) is the largest cephalexin importer from India with a 28.0% market share and import value of $98.0M.

Q: How many cephalexin buyers import from India?

There are 516 active cephalexin buyers importing from India, with a combined import market of $349.5M across 5,117 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top cephalexin buyers from India?

The top 5 cephalexin buyers — ASCEND LABORATORIES, LLC C/O UPS, ASCEND LABORATORIES,LLC, ASCEND LABORATORIES, LLC.,, ASCEND LABORATORIES, LLC, ASCEND LABORATORIES LLC — together control 68.3% of total cephalexin import value from India.

Suresh Sormare

Cephalexin

India Pharmaceutical Trade Intelligence

$349.5M223 Suppliers104 CountriesHS 30042012

ExportsIndia → UNITED STATES82.2%India → SRI LANKA5.2%

ImportsUNITED STATES → India$146.5K CROATIA → India$17.9K

#1 Supplier: ALKEM LABORATORIES #1 Buyer: ASCEND LABORATORIES,

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $287.1M through 596 shipments. This represents a market share of 82.2% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• ASCEND LABORATORIES, LLC C/O UPS - $98.0M (34.1% of country's total business)

• ASCEND LABORATORIES,LLC - $66.3M (23.1% of country's total business)

• ASCEND LABORATORIES, LLC., - $42.9M (15.0% of country's total business)

• ASCEND LABORATORIES, LLC - $18.8M (6.5% of country's total business)

• ASCEND LABORATORIES LLC - $12.7M (4.4% of country's total business)

• Rest of United States's importers - $48.4M (16.9% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $481.8K, indicating premium pricing strategy compared to the market average of $68.3K.

United States is a key market for Cephalexin imports, representing 82.2% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Cephalexin buyer market intelligence

1Buyer Segment Analysis

The importation of Cephalexin from India involves various buyer segments, each with distinct purchasing behaviors:

1. Distributors: Entities like ASCEND LABORATORIES, LLC, which appears under multiple entries in our data, function as primary distributors. They procure large volumes to supply to pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by bulk orders and a high frequency of transactions to maintain a steady supply chain.

2. Hospital Groups: Organizations such as M/S. SUN PHARMA ANZ PTY LTD in Australia likely represent hospital groups or healthcare networks. They import Cephalexin to meet the therapeutic needs of their patient populations, often engaging in tender-based procurement to secure favorable pricing and ensure consistent supply.

3. Retail Chains: While not explicitly listed among the top buyers, retail pharmacy chains in various countries import Cephalexin to stock their outlets. Their purchasing behavior includes regular, moderate-sized orders to align with consumer demand and manage inventory effectively.

4. Government Procurement: Entities like BREATHEFREE LANKA PVT LTD in Sri Lanka may be involved in government procurement processes, supplying Cephalexin for public health initiatives. These buyers typically engage in large-scale, periodic purchases through formal tender processes to ensure the availability of essential medicines in public healthcare facilities.

5. Re-exporters: Companies such as UNIQUE PHARMA in the Democratic Republic of Congo might act as re-exporters, importing Cephalexin from India to distribute it to neighboring regions. Their purchasing patterns involve bulk acquisitions, followed by redistribution to various markets.

6. Contract Manufacturers: Some buyers may function as contract manufacturers, importing Cephalexin as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is characterized by large, consistent orders aligned with production schedules.

Country-Specific Import Regulations

TransData Nexus Cephalexin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process for Cephalexin: Importers must ensure that Cephalexin is manufactured in facilities compliant with FDA regulations. The product must be approved under an Abbreviated New Drug Application (ANDA) or a New Drug Application (NDA).

3. Estimated Timeline for Registration: The approval process for an ANDA typically takes 10 months, though timelines can vary based on the completeness of the application and FDA workload.

4. Import Tariff/Duty for HS 30042012: Pharmaceutical products under HS Code 30042012 are generally duty-free in the United States.

Sri Lanka

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process for Cephalexin: Importers must obtain registration from the NMRA, which involves submitting product dossiers, certificates of analysis, and compliance with labeling requirements.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the submission and regulatory reviews.

4. Import Tariff/Duty for HS 30042012: Pharmaceuticals under this HS code are subject to a duty of 0% to 15%, depending on the product and applicable trade agreements.

Australia

1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).

2. Import Registration Process for Cephalexin: Cephalexin must be listed or registered in the Australian Register of Therapeutic Goods (ARTG). Importers need to provide evidence of Good Manufacturing Practice (GMP) compliance and product efficacy.

3. Estimated Timeline for Registration: The registration process can take 6 to 12 months, depending on the category of registration and the quality of the application.

Demand Drivers & Market Opportunity

TransData Nexus Cephalexin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Cephalexin in importing countries is influenced by several factors:

1. Disease Prevalence: Cephalexin is commonly prescribed for bacterial infections such as respiratory tract infections, skin infections, and urinary tract infections. High prevalence rates of these conditions in various regions drive the demand for effective antibiotics.

2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the WHO recommends tendering for pharmaceutical products, considering factors like product quality, availability, and supply security.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines, including antibiotics like Cephalexin, to ensure broader access to healthcare services.

4. WHO Essential Medicines List Procurement: Cephalexin's inclusion in the WHO Essential Medicines List prompts countries to prioritize its procurement to meet public health needs.

5. Tender-Based Purchasing: Many governments and healthcare organizations utilize tender-based purchasing to procure medicines cost-effectively. This approach ensures a steady supply of essential drugs like Cephalexin, aligning with public health objectives.

Our data indicates that 516 buyers across 104 countries have imported Cephalexin from India, reflecting its global demand and the critical role it plays in treating bacterial infections worldwide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Cephalexin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest cephalexin buyer importing from India?

Based on import volume and value, ASCEND LABORATORIES, LLC C/O UPS (UNITED STATES) leads with $98.0M in imports and a 28.0% market share — the highest of any single cephalexin importer. ASCEND LABORATORIES,LLC (UNITED STATES) and ASCEND LABORATORIES, LLC., (UNITED STATES) are the next largest buyers.

QHow many companies buy cephalexin from India?

There are 516 active cephalexin buyers importing from India, with a combined market of $349.5M across 5,117 shipments to 104 countries. The top 5 buyers hold 68.3% of total import value, while the remaining 511 buyers handle the other 31.7%.

QWhich countries import the most cephalexin from India?

The top importing countries for cephalexin from India are United States (82.2%), Sri Lanka (5.2%), Australia (2.4%), Ecuador (1.7%), Tanzania (1.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of cephalexin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for cephalexin from India?

The average import transaction value for cephalexin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Cephalexin buyer market intelligence

1Buyer Segment Analysis

The importation of Cephalexin from India involves various buyer segments, each with distinct purchasing behaviors:

Country-Specific Import Regulations

TransData Nexus Cephalexin buyer market intelligence

1Country-Specific Import Regulations

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

3. Estimated Timeline for Registration: The approval process for an ANDA typically takes 10 months, though timelines can vary based on the completeness of the application and FDA workload.

4. Import Tariff/Duty for HS 30042012: Pharmaceutical products under HS Code 30042012 are generally duty-free in the United States.

Sri Lanka

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the submission and regulatory reviews.

4. Import Tariff/Duty for HS 30042012: Pharmaceuticals under this HS code are subject to a duty of 0% to 15%, depending on the product and applicable trade agreements.

Australia

1. Drug Regulatory Authority: Therapeutic Goods Administration (TGA).

3. Estimated Timeline for Registration: The registration process can take 6 to 12 months, depending on the category of registration and the quality of the application.

Demand Drivers & Market Opportunity

TransData Nexus Cephalexin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Cephalexin in importing countries is influenced by several factors:

4. WHO Essential Medicines List Procurement: Cephalexin's inclusion in the WHO Essential Medicines List prompts countries to prioritize its procurement to meet public health needs.

Our data indicates that 516 buyers across 104 countries have imported Cephalexin from India, reflecting its global demand and the critical role it plays in treating bacterial infections worldwide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Cephalexin

Cephalexin

Who Buys Cephalexin from India — 516 Importers Behind a $349.5M Market

Top Cephalexin Importers — Ranked by Import Value

Top Cephalexin Buyers & Importers

Related Analysis

Need Details?

Cephalexin — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Cephalexin — and from which countries?

Cephalexin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Cephalexin Buyers & Importers

QWho is the largest cephalexin buyer importing from India?

QHow many companies buy cephalexin from India?

QWhich countries import the most cephalexin from India?

QWhat is the average import order value for cephalexin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Sri Lanka

3Australia

4Ecuador

5Tanzania

Analysis Methodology